About Adam D. Sussman
Adam Sussman combines broad scientific and technical expertise with outstanding fact and legal research and superlative writing skills in order to drive litigation forward to successful outcomes for clients. Adam is respected as an efficient and passionate advocate who supports the firm’s patent litigation practice and facilitates clients’ goals. His commitment to client service extends beyond his clients’ litigation needs, and includes strategic consultation, advice, and patent protection for highly specialized technologies.
Adam specializes in Hatch-Waxman pharmaceutical patent litigation, applying his advanced scientific knowledge to help overturn brand patents and bring generic versions of medicines swiftly and effectively to the marketplace. In his prosecution practice, Adam provides insightful scientific analyses, skillfully articulated applications, and determined advocacy before the USPTO and EPO in order to efficiently secure patent protection for his clients’ inventions.
Representative drug formulations/products litigated include levothyroxine sodium for injection, Pradaxa, Restasis, Gilenya, Nexium, Abilify, Botox, Treanda, OxyContin, and Byvalson.
In addition to enjoying exercise, running half-marathons, and traveling, Adam has served on the board of Sinai Children’s Hospital since 2009. He lives with his French bulldog, Gambini, in the heart of the City of Chicago.